The PROMAGEN Study: Quality of life
A randomised controlled study shows supplementation of overweight and obese adults with Lactobacilli and Bifidobacteria reduces bodyweight and improves wellbeing
SUMMARY
An exploratory, block-randomised, parallel, double-blind, single-centre, placebo-controlled superiority study with 220 overweight and obese adults with BMI 25-34.9. The probiotic group (110) took 50 billion Lab4P probiotics every day for six months and the placebo group (110) took an identical-looking placebo.
Significant improvements in Quality of Life scores of general wellness, health, energy and mood were observed in the overweight and obese adults supplemented with Lab4P probiotics.
Aim
This randomised, double-blind, placebo-controlled study aimed to assess the effect of 6-months’ supplementation with the Lab4P probiotic on body weight, plasma cholesterol and wellbeing in healthy overweight and obese individuals. The outcomes of the Quality of Life assessment are presented here.
Method
Results
Conclusion
Study links
2020
The PROMAGEN Study: Weight loss and Cholesterol
A randomised controlled study shows supplementation of overweight and obese adults with lactobacilli and bifidobacteria reduces bodyweight and improves well-being
2020
The PROMAGEN Study: Viral pandemic link?
Probiotics reduce self-reported symptoms of upper respiratory tract infection in overweight and obese adults: should we be considering probiotics during viral pandemics?
2020
The PROMAGEN Study: URTI Symptoms
A randomised controlled study shows supplementation of overweight and obese adults with lactobacilli and bifidobacteria reduces bodyweight and improves well-being
2021
The PROBE Study
Daily supplementation with the Lab4P probiotic consortium induces significant weight loss in overweight adults
